Frequent alterations in the expression of serine/threonine kinases in human cancers. - Wikidata - awgldk - TriplyDB

Frequent alterations in the expression of serine/threonine kinases in human cancers.

Frequent alterations in the expression of serine/threonine kinases in human cancers.

http://www.wikidata.org/entity/Q33998589

about

Identifying and characterizing a novel protein kinase STK35L1 and deciphering its orthologs and close-homologs in vertebrates STK35L1 associates with nuclear actin and regulates cell cycle and migration of endothelial cells The cognitive cell: bacterial behavior reconsidered A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases An Autoinhibitory Tyrosine Motif in the Cell-Cycle-Regulated Nek7 Kinase Is Released through Binding of Nek9 Insights into protein kinase regulation and inhibition by large scale structural comparison Altered serine/threonine kinase activity in schizophrenia SGK3 is an androgen-inducible kinase promoting prostate cancer cell proliferation through activation of p70 S6 kinase and up-regulation of cyclin D1."Stop Ne(c)king around": How interactomics contributes to functionally characterize Nek family kinases The clinical value, regulatory mechanisms, and gene network of the cancer-testis gene STK31 in pancreatic cancer An atlas of altered expression of deubiquitinating enzymes in human cancer Human Nek6 is a monomeric mostly globular kinase with an unfolded short N-terminal domain.A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance.Predicting inactive conformations of protein kinases using active structures: conformational selection of type-II inhibitors.The histone methyltransferase Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis.A kinase shRNA screen links LATS2 and the pRB tumor suppressor Pirin inhibits cellular senescence in melanocytic cells.Identification of novel inhibitors of human Chk1 using pharmacophore-based virtual screening and their evaluation as potential anti-cancer agents.Hsp72 is targeted to the mitotic spindle by Nek6 to promote K-fiber assembly and mitotic progression.Discovery of microRNAs and transcript targets related to witches' broom disease in Paulownia fortunei by high-throughput sequencing and degradome approach.Transcriptome, microRNA, and degradome analyses of the gene expression of Paulownia with phytoplamsa.Nek6 and Hif-1α cooperate with the cytoskeletal gateway of drug resistance to drive outcome in serous ovarian cancer.TGF-β3 Inhibits Antibody Production by Human B Cells.Enhanced Cardiac Regenerative Ability of Stem Cells After Ischemia-Reperfusion Injury: Role of Human CD34+ Cells Deficient in MicroRNA-377.Translocation t(11;14) (q13;q32) and genomic imbalances in multi-ethnic multiple myeloma patients: a Malaysian study.Powerful Set-Based Gene-Environment Interaction Testing Framework for Complex Diseases.Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis.The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation.Coordinated regulation of serum- and glucocorticoid-inducible kinase 3 by a C-terminal hydrophobic motif and Hsp90-Cdc37 chaperone complex Quinazoline derivatives as potential anticancer agents: a patent review (2007 - 2010).Aberrant signaling pathways in glioma.Novel thiazole derivatives: a patent review (2008 - 2012; Part 1).Quinazoline derivatives as anticancer drugs: a patent review (2011 - present).Approaches to identify kinase dependencies in cancer signalling networks.Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myeloma.Clinical outcome of treatment with serine-threonine kinase inhibitors in recurrent epithelial ovarian cancer: a systematic review of literature.Nek7 Protects Telomeres from Oxidative DNA Damage by Phosphorylation and Stabilization of TRF1.Investigational serine/threonine kinase inhibitors against prostate cancer metastases.Expression profile of genes regulated by curcumin in Y79 retinoblastoma cells.The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review).

P2860

Q21142750-48FFC346-8D22-4296-8B32-C950C20ADB10 Q21562117-6E9FF7C0-5E33-4855-943A-FF313C0BB7EF Q26824926-63CF0A0C-0E9B-4816-AEEC-6FABC964E1D4 Q27649303-ABB9767C-6E9D-41EA-A95F-05C031FDCAD0 Q27658342-16435A2C-FF7F-4514-8B2E-AE20257401C0 Q30381908-7D2F01EC-9372-46DC-AC7E-643911BC3952 Q30409979-C4773229-7120-45E0-B406-BC0D5504CB6E Q33701389-CDC9EBC4-F07D-471E-8F43-A4507E725DB7 Q33728829-9F8DDAB6-5E6A-4D90-BD88-4E8D0A485F11 Q33798766-D7FAEE8B-604E-44CA-88B3-BBA01F388F3F Q33808690-69FA90CD-38BB-468E-9821-BED532EEB649 Q33820240-7BCC3EB9-086E-4ECF-9926-659A5406EEFF Q33875566-3780526D-C3AE-4407-BF0B-794FBF0187C6 Q33983328-6A10DE4D-B5D6-4AF7-A9E9-F63B3846B35E Q34301910-EBF90220-BE90-402F-A5FD-72E205E17ED1 Q34807689-51E71636-D421-44DB-B102-CA7AEC68CF91 Q34838382-50513B3B-0924-406B-A7C6-CE7C9CADFFB1 Q35329233-D36E6C29-7E6B-42F1-90D6-FC555EA9A01C Q35594561-18D3BE57-8B32-44F0-BCDF-77DC74549B2C Q35738040-30D52C0D-45AF-49CC-B05E-050985C1CAEB Q35832766-F1B0E3A4-BF29-43DA-9CB3-C0DAEB91DA0C Q35929796-222F1E15-0DB0-45AE-8B0D-7CABF7BE77AF Q36239510-834B7CAD-4788-475B-8696-43695BB8B885 Q36278997-1441F92A-AB0B-4A8E-BBCE-22386824674A Q36331764-7ED88B5E-5A60-42E8-96A1-C9817BF8CCE1 Q36363009-5F1A6DF8-3BA9-49F9-B899-CC34CEA03F81 Q36944020-3B2AA30C-F505-402C-836C-444F509DB59B Q37237119-7BA5B0BF-0B59-42A6-AEC0-85DF4E848248 Q37596323-F1670707-67C2-44BC-93BE-3BE96E406D58 Q37992086-BEB2E0F1-D951-48BB-BC3E-B371125965DE Q38161369-BB8F6201-EAE7-42FF-AB46-D385C639BCE7 Q38161545-8B767D6B-2B82-4318-B937-1CE803136267 Q38440766-24737498-CAE3-44E1-A394-61E7C52AB51F Q38660465-84E687BE-6E57-4A6F-8266-09C203E392C4 Q38720908-23CAAC39-A902-4FB0-84A0-B4FAEE830D45 Q38813996-C368CB4A-853F-4702-ABFC-8A49128E7F56 Q38952935-6EE6BDBA-D70B-4D09-A136-6E5A2065CD7F Q39021945-ECADACF4-0998-487B-ACD5-E479CFC77F93 Q39366939-ECCEDEFE-8FA9-4AE3-9C55-40E5A595CD8C Q39401616-A1004637-C231-40D5-BC41-5FE033BBE451

P2860

Frequent alterations in the expression of serine/threonine kinases in human cancers.

http://www.wikidata.org/entity/Q33998589

description

2006 nî lūn-bûn

@nan

2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Frequent alterations in the expression of serine/threonine kinases in human cancers.

@ast

Frequent alterations in the expression of serine/threonine kinases in human cancers.

@en

type

label

Frequent alterations in the expression of serine/threonine kinases in human cancers.

@ast

Frequent alterations in the expression of serine/threonine kinases in human cancers.

@en

prefLabel

Frequent alterations in the expression of serine/threonine kinases in human cancers.

@ast

Frequent alterations in the expression of serine/threonine kinases in human cancers.

@en

P1433

Q33998589-FCA3311D-DAC0-4674-957E-09E2B1C39FEF

P1476

Q33998589-4D190FF4-64A7-48B9-B1FD-78C980FEA3E4

P2093

Q33998589-631D20A8-89A3-4971-82CD-560847EECF90

Q33998589-D740C31B-96EA-44CC-A66C-7779762E26DB

Q33998589-DC5E6448-8D5C-45FF-8A17-0E7DFB732DFD

Q33998589-E1D7D360-F24C-46DC-8076-A5212F82F931

Q33998589-EB4BF1FA-41C1-4F69-B9FC-A49F3F2BB292

Q33998589-EF18F9DC-344F-4F67-8052-F55CCA832E62

Q33998589-F3BFFC43-8C35-446A-9243-65137CA605F9

Q33998589-F5110BA8-A388-4E1D-9E0C-BF8792CE34D7

P304

Q33998589-815D684F-45F5-485E-8EC6-49257EA7DA81

P31

Q33998589-60D91C84-788C-4C34-8E8F-1269C6CF4876

P356

Q33998589-9CE19D2A-4BE5-4CB6-BA1D-F4F77FA52329

P407

Q33998589-99A6DE61-94BF-4F1C-99FD-5B0DE8C3C82F

P433

Q33998589-DB395BB8-E2A1-4430-B3AB-F62D114CBBDE

P478

Q33998589-04C9E9D8-C8B7-45FC-8747-6A9256BD799F

P50

Q33998589-421DEB19-300F-4DAE-B123-DA9051B97884

Q33998589-80124AE0-2A5C-4CD4-8AEC-65265FDABB4D

Q33998589-C7F244E2-C8A7-4FF4-AA20-B4AE0DA5CFF6

Q33998589-EBDBD61D-A5BA-4E3E-B53D-B72EE2F01405

P577

Q33998589-2194AE25-6A50-44CE-A3F3-CC4C1ED7F62A

P5875

Q33998589-9434D276-0496-4E45-8462-2D3017C1063A

P698

Q33998589-F342197A-3932-4AE5-B847-17589CB20FAA

P356

0008-5472.CAN-05-3489

P1433

Cancer Research

P1476

Frequent alterations in the expression of serine/threonine kinases in human cancers.

@en

P2093

Francesco Pallotti

http://www.w3.org/2001/XMLSchema#string

Giulio F Draetta

http://www.w3.org/2001/XMLSchema#string

Marco Bianchi

http://www.w3.org/2001/XMLSchema#string

Maria Capra

http://www.w3.org/2001/XMLSchema#string

Micaela Quarto

http://www.w3.org/2001/XMLSchema#string

Mikhail L Gishizky

http://www.w3.org/2001/XMLSchema#string

Pier Paolo Di Fiore

http://www.w3.org/2001/XMLSchema#string

Renzo Boldorini

http://www.w3.org/2001/XMLSchema#string

P304

8147-8154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-05-3489

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Stefano Confalonieri

Manuela Nebuloni

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6875801

http://www.w3.org/2001/XMLSchema#string

P698

16912193

http://www.w3.org/2001/XMLSchema#string